Latest News & Updates
Breaking News
18 hours ago
Simantini Singh Deo
Sun Pharma amongst 2026 S&P Dow Jones Best-in-Class World Index
Mrudula Kulkarni
Other trending news you may like to read
Biocon Secures Malaysia MoH Insulin Supply Contracts Worth Over Rs. 515 Crore with Duopharma Biotech
Biocon wins Malaysia MoH insulin supply contracts worth over Rs. 515 crore, covering human insulin, glargine, and aspart via Duopharma Biotech.
Simantini Singh Deo
Sun Pharma amongst 2026 S&P Dow Jones Best-in-Class World Index
Sun Pharma joins the 2026 S&P Dow Jones Best-in-Class World Index, one of 317 global companies and 25 from India recognised for industry-leading sustainability performance.
Mrudula Kulkarni
FDA Finalizes Digital Health Technology Guidance Reshaping Remote Data Acquisition in Clinical Trials
FDA's final DHT guidance sets binding expectations for remote data acquisition in clinical trials, affecting protocol design and submission strategy.
Simantini Singh Deo
FDA Refreshes IND Safety Reporting Guidance Under 21 CFR 312.32 for IND Sponsors
FDA updates its IND safety reporting resource, clarifying 21 CFR 312.32 thresholds, timelines, and submission requirements for active IND sponsors.
Simantini Singh Deo
